Rozlytrek

(entrectinib)
entrectinib 100 MG Oral Capsule [Rozlytrek]entrectinib 200 MG Oral Capsule [Rozlytrek]
NO BLACK BOX WARNING

Dosage & administration

eficacy, safety & testing

Rozlytrek clinical details

Mechanism of Action (MOA)
Dosing & Administration
NTRK Testing
ROS1 Testing
Efficacy: NTRK Fusion-positive Solid Tumors
Safety Profile: NTRK Fusion-positive Solid Tumors
Efficacy: ROS1-positive Non-small Cell Lung Cancer (NSCLC)
Safety Profile: ROS1-positive Non-small Cell Lung Cancer (NSCLC)

drug label

Rozlytrek prescribing information

Have more Rozlytrek questions?

Submit MSL Request
Learn More

Need to report a Rozlytrek issue?

ONLINE FORM
Report adverse event
Learn More

prior authorization

Rozlytrek Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request
Coverage Authorization Appeals
Learn More

Benefits investigation

Rozlytrek Prescriber Service Form - Online Portal
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Rozlytrek Financial assistance options

Co-pay savings program

commercial only
Rozlytrek Prescriber Service Form - Online Portal
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Rozlytrek Prescriber Service Form - Online Portal
Genentech Patient Foundation Application Form (1/2)
Learn More

patient education

Rozlytrek Patient education

Getting started on Rozlytrek

NOT PROVIDED BY BRAND
Instructions For Use: NTRK Fusion-positive Solid Tumors

NOT PROVIDED BY BRAND
Instructions For Use: ROS1-positive Non-small Cell Lung Cancer (NSCLC)

Patient toolkit

Rozlytrek Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Rozlytrek: NTRK Fusion-positive Solid Tumors
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: NTRK Fusion-positive Solid Tumors
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Rozlytrek: NTRK Fusion-positive Solid Tumors
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Talking With Your Doctor: NTRK Fusion-positive Solid Tumors
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: NTRK Fusion-positive Solid Tumors
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Rozlytrek: ROS1-positive Non-small Cell Lung Cancer (NSCLC)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: ROS1-positive Non-small Cell Lung Cancer (NSCLC)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Rozlytrek: ROS1-positive Non-small Cell Lung Cancer (NSCLC)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Talking With Your Doctor: ROS1-positive Non-small Cell Lung Cancer (NSCLC)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: ROS1-positive Non-small Cell Lung Cancer (NSCLC)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Caregiver Tips
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Rozlytrek FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.